Putnam Investments LLC Alkermes Plc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Putnam Investments LLC holds 92,956 shares of ALKS stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,956

Previous 77,723 19.6%

Holding current value

$2.65 Million

Previous $2.18 Million 18.42%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $355,995 - $436,882	15,233 Added 19.6%	92,956 $2.58 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $56.7 Million - $66.8 Million	-2,087,936 Reduced 96.41%	77,723 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $7.34 Million - $8.71 Million	-259,074 Reduced 10.68%	2,165,659 $67.8 Million
Q1 2023 May 22, 2023	SELL	$25.31 - $29.02 $10.6 Million - $12.2 Million	-419,239 Reduced 14.74%	2,424,733 $68.4 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $38.1 Million - $45.5 Million	1,734,660 Added 156.37%	2,843,972 $74.3 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $9.08 Million - $13.2 Million	412,662 Added 59.24%	1,109,312 $24.8 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $16.3 Million - $18.8 Million	615,844 Added 762.13%	696,650 $20.8 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $140,565 - $170,543	-6,093 Reduced 7.01%	80,806 $2.13 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $7.1 Million - $10.6 Million	-330,901 Reduced 79.2%	86,899 $2.02 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $4.06 Million - $5.58 Million	-173,666 Reduced 29.36%	417,800 $12.9 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $7.7 Million - $10.3 Million	409,878 Added 225.72%	591,466 $14.5 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $74,824 - $95,328	-4,109 Reduced 2.21%	181,588 $3.39 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $58,820 - $84,466	-3,822 Reduced 2.02%	185,697 $3.71 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $14,333 - $18,325	-887 Reduced 0.47%	189,519 $3.14 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $76,319 - $111,296	-5,734 Reduced 2.92%	190,406 $3.7 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $2.56 Million - $4.17 Million	196,140 New	196,140 $2.83 Million
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $4.97 Million - $7.93 Million	-177,765 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $1.18 Million - $1.5 Million	29,202 Added 19.66%	177,765 $7.32 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $22,677 - $28,450	-423 Reduced 0.28%	148,563 $8.61 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $7.32 Million - $8.11 Million	148,986	148,986 $7.57 Million

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.69B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Alkermes Plc. Transaction History